This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Ovarian Cancer
  • /
  • Randomized Phase II Trial of Nivolumab Versus Nivo...
Journal

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Read time: 1 mins
Published:31st May 2020
Author: Zamarin D, Burger RA, Sill MW, Powell DJ Jr, Lankes HA, Feldman MD et al.
Availability: Pay for access, or by subscription
Ref.:J Clin Oncol. 2020 Jun 1;38(16):1814-1823.
DOI:10.1200/JCO.19.02059
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest